Evidence map›Paper›PMID 41728058›Full record

ArticleAccess microbiology2026

Human cytomegalovirus strain-specific differences in protein expression of type I IFN pathway proteins do not impact virus replication.

Katie A Latham, Timothy K Soh, Richard J Stanton, Jens B Bosse, Steve Goodbourn, Blair L Strang

Abstract read
In one paragraph

Article in Access microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katie A LathamInstitute of Infection & Immunity, St George's School of Health and Medical Sciences, City St George's University of London, London, UK.
Timothy K SohCentre for Structural Systems Biology, Hamburg, Germany.
Richard J StantonDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Jens B BosseCentre for Structural Systems Biology, Hamburg, Germany.
Steve GoodbournInstitute of Infection & Immunity, St George's School of Health and Medical Sciences, City St George's University of London, London, UK.
Blair L StrangInstitute of Infection & Immunity, St George's School of Health and Medical Sciences, City St George's University of London, London, UK.ORCID https://orcid.org/0000-0001-9407-1974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The type I IFN response is crucial for cells to restrict viral replication during infection. Many viruses, including human cytomegalovirus (HCMV), have evolved mechanisms to antagonize the type I IFN response. We have previously observed an increase in protein expression of certain IFN-stimulated genes when comparing the high-passage HCMV strain AD169 to the low-passage strain HCMV Merlin, suggesting that AD169 is defective in its ability to inhibit type I IFN function. To better understand HCMV interaction with the type I IFN response, we examined expression of cellular and viral proteins expressed in Merlin- and AD169-infected cells associated with IFN production and signalling. HCMV IFN antagonists expressed by both viruses had differences in amino acids throughout their protein sequences, although analysis using AlphaFold revealed that there was likely to be no obvious differences in the overall structure of these proteins. Analysis of quantitative mass spectrometry datasets showed modest differences in the expression of cellular IFN-associated proteins between strains. Contrary to previously reported data, we found no obvious loss of IRF3 expression, though this may be due to experimental differences between studies. These data revealed that multiplicity of infection was an important factor in IRF3 expression. We found little or no statistical difference in the production of IFN-

Indexed as

alphafoldcytomegalovirushumanIFN

Identifiers

PMID41728058
PMCPMC12917765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.